Latest / The Diagnostics & Lab Testing Business Brief
Senseonics Freedom One-Year CGM First-in-Human Study, Roche Diagnostics Sales, Delfi-Pro at ESMO — Oct 26, 2026
The Diagnostics & Lab Testing Business Brief — Monday, October 26, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
DEVICE — Senseonics begins first-in-human study of Freedom CGM: announced Oct 26, 2026 — an investigational, transmitter-free one-year CGM designed to communicate directly with a mobile device (integrated battery, embedded Bluetooth; built on Eversense 365 sensing technology). Early feasibility study of safety and function; pivotal study expected 2027; potential commercial launch targeted 2028. Investigational — not FDA cleared or…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.